Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Collaboration › Details

Exscientia–Goldman Sachs: investor conference, 202306 supply service Exscientia presents at Goldman Sachs Annual Global Healthcare Conference 2023

 

Period Period 2022-11-29
Organisations Partner, 1st Exscientia plc (Nasdaq: EXAI)
  Group Exscientia (Group)
  Partner, 2nd Goldman Sachs & Co. LLC
Products Product Goldman Sachs Annual Global Healthcare Conference 2023 Dana Point
  Product 2 AI-based drug discovery / AI-based drug development
     

Exscientia plc. (6/6/23). "Press Release: Exscientia to Present at the Goldman Sachs 44th Annual Global Healthcare Conference". Oxford.

Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13, 2023, at 11:20 a.m. PDT (7:20 p.m. BST).

A live webcast of the fireside chat will be available on the Company’s website, under the “Investors & Media” section at investors.exscientia.ai. An archived replay of the webcast will be available for approximately 30 days following the presentation.


About Exscientia

Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

For more information visit us on https://www.exscientia.ai or follow us on Twitter @exscientiaAI.


Investor Relations:
Sara Sherman
investors@exscientia.ai

Media:
Oliver Stohlmann
media@exscientia.ai

   
Record changed: 2023-06-06

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Exscientia (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x300px




» top